TherapeuticsMD (TXMD) Misses Q1 EPS by 2c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/14/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
TherapeuticsMD Announces First Quarter 2020 Financial Results
May 6, 2020 6:50 AM EDT- 1Q20 total net product revenue of $12.3 million exceeded Wall Street consensus -
- Significantly reducing operating expenses, while maintaining goal of achieving EBITDA breakeven in 2021 -
- In discussions with TPG Sixth Street Partners to defer the scheduled start of quarterly revenue covenants due to COVID-19 -
- First Orange Book listed patent for ANNOVERA® issued providing potential extended exclusivity to 2039 -
- Strengthened board of directors with diverse industry veterans -
- Conference call scheduled for... More
